Top Markets
Coin of the day
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Classement en actions #25185
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Prix de l'action
$1.95
Dernière synchronisation: 2022-07-29
Capitalisation boursière
$52.48M
Changement (1 jour)
2.63%
Changement (1 an)
0.00%
Pays
US
Échange Cortexyme, Inc. (CRTX)

Catégorie

Historique du prix de l'action pour Cortexyme, Inc. (CRTX)
Prix de clôture le plus élevé : $2.18 le 2022-07-01

Prix de clôture le plus bas : $26.37 le 2019-05-01
Historique du prix de l'action de Cortexyme, Inc. de 2019 à 2026
Performance annuelle du prix de l'action
Année Performance
2022 -82.87%
2021 -62.60%
2020 -23.16%
2019 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.57 8.46%
CH
$130.43 397.46%
US